“CHPA advocates tirelessly to reinforce the value of OTC medicines, dietary supplements, and consumer medical devices and strengthen their relevance, importance, and credibility among key thought leaders and influencers.”

— Scott Melville, President & CEO, CHPA


Congress Passes and President Signs into Law Historic COVID-19 Aid Bill; Includes OTC Monograph Reform

On March 27, 2020, President Donald J. Trump signed into law H.R. 748, the “Coronavirus Aid, Relief, and Economic Security Act” or “CARES Act,” ushering in an exciting new chapter in OTC medicine history. The CARES Act included groundbreaking OTC Monograph reform legislation, which capped a multi-year effort to pass this landmark legislation, and will shape the future of OTC drugs for decades to come.

OTC Monograph Reform Infograph Snippet

New OTC Monograph Reform Q&A Available!

View CHPA’s OTC Monograph Reform – Frequently Asked Questions. This document will be updated on a regular basis, as discussions with members continue.



After a decade of lobbying, thanks to the unwavering effort of CHPA members and staff, 60+ million consumers can once again use their pre-tax HSA and FSA accounts to purchase OTC medicines without a prescription; and, for the first time ever, menstrual care products as well! When President Trump signed the CARES Act into law on March 27, 2020, it included the restoration of this key benefit and put wellness back in Americans’ wallets.

Million Consumers
CHPA-HSA-FSA-Wallet-TW-Relief2 (1)

Introducing Insights with Impact

As CHPA formally embraces a more holistic self-care approach, we've broadened our scope within the health policy arena, and have developed a public policy section of the website, where you will find critical health policy themes or developments that help your business thrive.